Allspring Global Investments’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Allspring Global Investments’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-940	Closed	-$64K	–	2987
2022 Q3	$64K	Sell	940 -3,393	-78%	-$187K	﹤0.01%	2254
2022 Q2	$138K	Sell	4,333 -38,371	-90%	-$1.12M	﹤0.01%	1949
2022 Q1	$1.48M	Buy	42,704 +5,377	+14%	+$161K	﹤0.01%	1667
2021 Q4	$1.09M	Buy	+37,327	New	+$1.16M	﹤0.01%	1884

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Allspring Global Investments's GBT Position: Q4 2022 in Review

Allspring Global Investments sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 940 shares — an estimated $64K sold.

Allspring Global Investments first reported a position in GBT in Q4 2021 and held it in 4 quarters. The position peaked at $1.48M in Q1 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Allspring Global Investments reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Allspring Global Investments sold 940 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $64K.
Allspring Global Investments first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and held it in 4 quarters.
Allspring Global Investments's Global Blood Therapeutics, Inc. position peaked at $1.48M in Q1 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Allspring Global Investments's 13F filing for Q4 2022, filed 23 Jan 2023.